
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
nm23-H2 CRISPR/Cas9 KO Plasmid (h) | sc-416164 | 20 µg | $397.00 |
NME1-NME2 encodes nm23-H2, a nucleoside diphosphate kinase that helps maintain cellular nucleotide homeostasis by catalyzing phosphate transfer between NTPs and NDPs. Beyond its metabolic role, nm23-H2 participates in regulation of gene expression and signaling networks linked to proliferation, differentiation, and stress responses, with reported functions in nucleic acid binding and transcriptional control in the nucleus. Altered NME1/NME2 activity and expression patterns have been associated with tumor progression and metastatic behavior in multiple cancer contexts, making it a useful node for mechanistic studies of invasion and cell-state transitions. In human cells, nm23-H2 is also studied in relation to cytoskeletal remodeling and motility pathways that influence migration phenotypes.
nm23-H2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NME1-NME2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NME1-NME2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NME1-NME2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish nm23-H2 protein expression.
This CRISPR knockout system enables efficient generation of NME1-NME2-deficient cell models for investigation of nm23-H2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.